N/A
Completed N=21
Activating Behavior for Lasting Engagement After Stroke
Stroke · Physical Activity · Sedentary Lifestyle · Behavior, Health
Source: ClinicalTrials.gov NCT03305731 ↗
Enrolled (actual)
21
Serious AEs
0.0%
Results posted
Feb 2020
Primary outcomePrimary: Change in Daily Sedentary Time Accumulated in Bouts Greater Than or Equal to 30 Minutes — 54.95 minutes
Summary
Stroke survivors demonstrate high levels of sedentary behavior, placing them at risk for exacerbation of chronic health conditions. This may lead to recurrent stroke. Subtle cognitive impairments are common after stroke and can lead to difficulty self-monitoring and problem solving to overcome barriers to physical activity. Investigators developed the Activating Behavior for Lasting Engagement (ABLE) intervention to promote activity scheduling, self-monitoring, and problem solving activity over the full day. This study examines the effects of the ABLE intervention on sedentary behavior after stroke.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Daily Sedentary Time Accumulated in Bouts Greater Than or Equal to 30 Minutes |
14.08 | — |
| PRIMARY Change in Daily Number of Sedentary Breaks |
-2.55 | — |
| SECONDARY Change in Daily Number of Sedentary Breaks |
-2.55 | — |
| SECONDARY Change in Daily Sedentary Time Accumulated in Bouts Greater Than or Equal to 30 Minutes |
14.08 | — |
| SECONDARY Change in Participation |
1.33 | — |
Eligibility Criteria
Inclusion Criteria
- diagnosis of ischemic or hemorrhagic stroke
- ≥6 months and ≤24 months post-stroke
- ≥18 years of age
- ambulatory in the community with or without an assistive device (e.g. walker, cane)
- self-reported sedentary behavior (≥6 hours/day of sedentary behavior reported using the Sedentary Behavior Questionnaire)
- reside within 50 miles of Pittsburgh, Pennsylvania
Exclusion Criteria
- severe aphasia (Boston Diagnostic Aphasia Examination score ≤1)
- currently receiving outpatient or home care rehabilitation services (physical therapy, occupational therapy, or speech therapy)
- current active cancer treatment
- medical history of neurodegenerative disorder (i.e. dementia, Parkinson's disease, multiple sclerosis, Lou Gehrig's disease (ALS), glioblastoma, myasthenia gravis)
- current major depressive disorder, psychiatric condition, substance abuse (Patient Health Questionnaire-9, PRIME-MD/MINI)
Data sourced from ClinicalTrials.gov (NCT03305731). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.